Extracorporeal membrane oxygenation (ECMO) and beyond in near fatal asthma: A comprehensive review

• Published in: Respiratory medicine Vol. 215; p. 107246
• Main Authors: Lozano-Espinosa, María, Antolín-Amérigo, Darío, Riera, Jordi, Gordo Vidal, Federico, Quirce, Santiago, Álvarez Rodríguez, Joaquín
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.08.2023
• Subjects: ECCO2R; ECMO; Extracorporeal membrane oxygenation; ICU; Intensive care; Near fatal asthma; Severe asthma exacerbations; ECMO; Intensive care; Extracorporeal membrane oxygenation; Severe asthma exacerbations; ECCO2R; ICU; Near fatal asthma
• ISSN: 0954-6111; 1532-3064
• DOI: 10.1016/j.rmed.2023.107246

The treatment of choice in severe asthma exacerbations with respiratory failure includes ventilatory support, both invasive and/or non-invasive, along with different kinds of asthma medication. Of note, the rate of mortality of patients with asthma has decreased substantially in recent years mainly due to significant advances in pharmacological treatment and other management strategies. However, the risk of death in patients with severe asthma who require invasive mechanical ventilation has been estimated between 6.5% and 10.3%. When conventional measures fail, rescue strategies, such as extracorporeal membrane oxygenation (ECMO) or extracorporeal CO2 removal (ECCO2R) may need to be implemented. While ECMO does not constitute a definitive treatment per se, it can minimize further ventilator associated lung injury (VALI) and can enable diagnostic-therapeutic maneuvers that cannot be performed without ECMO such as bronchoscopy and transfer for diagnostic imaging. Asthma is one of the diseases that is associated with excellent outcomes for patients with refractory respiratory failure requiring ECMO support, as shown by the Extracorporeal Life Support Organization (ELSO) registry. Moreover, in such situations, the use of ECCO2R for rescue has been described and utilized in both children and adults and is more widely spread in different hospitals than ECMO. In this article, we aim to review the evidence for the usefulness of extracorporeal respiratory support measures in the management of severe asthma exacerbations that lead to respiratory failure.